Company / Revenue per Share
Immunocore Holdings plc Revenue per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$7.99
FY2025
5-year range
$0.86 / $7.99
FY2021-FY2025
Trend
+28.1%
vs FY2024
Sector context
#53 of 154
Health Care
What the data says
At $7.99, Immunocore Holdings plc's revenue per share ranks #53 of 154 in the Health Care sector. Revenue per Share has increased for 4 consecutive years, from $0.86 in FY2021 to $7.99 in FY2025.
Based on SEC 10-K filings.
7.99 in FY2025 with a 3-year CAGR of +28.0%.
Improved from $5.19 to $7.99 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +28.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#53 of 154 in Health CareTop 34% of 154This company $7.99 Sector average $15.09
▼
-47.1% below sector average
Key checks
Key Insights
- Immunocore Holdings plc's revenue per share has grown for 4 consecutive years.
- In FY2025, revenue per share increased 28.1% year-over-year.
- Ranks #53 out of 154 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.99 | +28.1% |
| FY2024 | $6.24 | +20.3% |
| FY2023 | $5.19 | +36.0% |
| FY2022 | $3.81 | +344.2% |
| FY2021 | $0.86 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026